These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4096751)

  • 1. Pharmacokinetics of cefotaxime in the postpartum patient.
    Gonik B; Cotton DB; Feldman S; Cleary TG; Pickering LK
    Am J Perinatol; 1985 Apr; 2(2):114-7. PubMed ID: 4096751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates.
    Kearns GL; Jacobs RF; Thomas BR; Darville TL; Trang JM
    J Pediatr; 1989 Mar; 114(3):461-7. PubMed ID: 2921690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR; Abraham PA; Halstenson CE; Keane WF
    Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotaxime in sheep.
    Guerrini VH; Filippich L; English PB; Bourne DW
    Am J Vet Res; 1983 Aug; 44(8):1488-91. PubMed ID: 6312852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.
    Beyssac E; Cardot JM; Colnet G; Sirot J; Aiache JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):91-102. PubMed ID: 3691581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography.
    Kees F; Strehl E; Seeger K; Seidel G; Dominiak P; Grobecker H
    Arzneimittelforschung; 1981; 31(2):362-5. PubMed ID: 6261772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elimination of desacetyl cefotaxime in geriatric patients with multiple diseases].
    Mühlberg W; Platt D
    Klin Wochenschr; 1982 Dec; 60(24):1497-500. PubMed ID: 6300510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the pharmacokinetics of cefotaxime in neonates].
    Nishimura T; Takashima T; Hiromatsu K; Tabuki K
    Jpn J Antibiot; 1982 Jul; 35(7):1793-800. PubMed ID: 6294360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of clinical application of cefotaxime in the perinatal period].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1982 Jul; 35(7):1855-76. PubMed ID: 6294366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefotaxime in healthy volunteers and patients.
    Patel KB; Nicolau DP; Nightingale CH; Quintiliani R
    Diagn Microbiol Infect Dis; 1995; 22(1-2):49-55. PubMed ID: 7587050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates.
    Crooks J; White LO; Burville LJ; Speidel BD; Reeves DS
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():97-101. PubMed ID: 6094467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function.
    Ings RM; Fillastre JP; Godin M; Leroy A; Humbert G
    Rev Infect Dis; 1982; 4 Suppl():S379-91. PubMed ID: 6294787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.